Patents expiring in 2031

US 7879838

Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity

Pharmacopeia Drug Discovery, Inc. · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879834

Spiroindoline modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879909

Use of Treprostinil to treat neuropathic diabetic foot ulcers

United Therapeutics Corporation · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879874

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7880007

Bicyclic substituted phenyl piperidine modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7880008

Heterocycles useful as modulators of ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879984

Human antibodies to human CD20 and method of using thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7880010

Crystalline forms of a dimethylphenyl compound

Theravance, Inc. · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879576

Marine actinomycete taxon for drug and fermentation product discovery

The Regents of the University of California · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879856

Diaminothiazoles useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879801

Compositions comprising cell-impermeant duramycin derivatives

The Board of Regents of the University of Texas System · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879879

Biphenyl derivatives

Theravance, Inc. · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879548

Detection of biomarkers for neuropsychiatric disorders

The Regents of the University of California · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879792

Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879810

Immunostimulatory nucleic acid molecules

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879896

Dual-acting imidazole antihypertensive agents

Theravance, Inc. · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879564

Use of the receptor GPR86

Takeda Pharmaceutical Company Limited · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879334

Fusion molecules and treatment of IgE-mediated allergic diseases

The Regents of the University of California · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879891

Caspase inhibitor prodrugs

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879370

Composition of which chief ingredient is polysaccharides having an immunoregulatory function

American Regent, Inc. · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879324

Fusion molecules and methods for treatment of immune diseases

The Regents of the University of California · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7879798

Composition for indolent wound healing and methods of use therefor

Regenicel, Inc. · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7884111

2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7884066

NELL-1 enhanced bone mineralization

The Regents of the University of California · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7883892

Swine multipotent adult progenitor cells

Regents of the University of Minnesota · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7884091

Methods for treating delirium using glucocorticoid receptor-specific antagonists

Corcept Therapeutics Incorporated · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7884211

Dimeric small molecule potentiators of apoptosis

The Board of Regents of the University of Texas System · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7884119

Triazole derivatives useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7884226

Purification of rosuvatatin intermediate by thin film evaporation and chemical method

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7884208

Crystals of laquinimod sodium, and process for the manufacture thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7884178

Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7884234

N-phenyloxamide derivatives

Institute of Medicinal Molecular Design, Inc. · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7884199

HCV NS3-NS4 protease resistance mutants

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7883881

Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7883710

Peptide vaccines against Group A streptococci

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2760177

FORMULATION ALIMENTAIRE COMPRENANT DU GLYCOGENE

ACRAF [IT] · Granted Thu Feb 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7887829

Mucosal cell composites and methods

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7887836

Compositions and methods for treating lymphoma

The Board of Regents of the University of Texas System · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7887789

Polymer derivatives having particular atom arrangements

Nektar Therapeutics · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7887812

Live attenuated Leishmania vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7888068

Cloning of honey bee allergen C

PLS-Design GmbH · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7888070

Nucleic acids encoding growth hormone with a modified RSP sorting signal

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7888069

Plant-made west nile virus (WNV) vaccines, vectors and plant codon optimized sequences

The United States of America as represented by the Secretary of Argriculture · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7888332

Hydrazide-containing CFTR inhibitor compounds and uses thereof

The Regents of the University of California · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7888357

Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death

Northwestern University · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7887818

Neospora caninum vaccine

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7888116

Uses of notch receptors, notch ligands, and notch modulators in methods related to metabolic diseases

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7888121

Methods and compositions for targeted cleavage and recombination

Sangamo Biosciences, Inc. · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)